Tobrex, eye drops 0.3% 5 ml
€3.86 €3.43
Tobrex eye drops contain tobramycin, a broad-spectrum antibiotic of the aminoglycoside group. Bactericidal effect of the drug extends to Streptococcus and Staphylococcus bacteria, Klebsiella, Escherichia coli, diphtheria bacteria.
In low concentrations the action is bacteriostatic (blocks 30S ribosome subunit and disturbs protein synthesis) and in higher concentrations it is bactericidal (disturbs cytoplasmic membrane function, causing death of microbial cell).
Highly active against Staphylococcus spp. (including Staphylococcus aureus, Staphylococcus epidermidis /coagulase-negative and coagulase-positive/ and penicillin-resistant strains); Streptococcus spp.including α-β-haemolytic species, some non-haemolytic species, Streptococcus pneumoniae); Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumoniae, Enterobacter aerogenes, Proteus mirabilis (indole-negative) and indole-positive species of Proteus spp, Haemophilus influenzae, Haemophilus aegyptius, Moraxella lacunata, Acinetobacter calcoaceticus (Herellea vaginacola), some Neisseria spp. species (including Neisseria gonorrhoeae).
Pharmacokinetics
In local administration systemic absorption is low.
Indications
Eye Infections, Eye Redness, Blepharitis, Iridocyclitis, Conjunctivitis, Inflammatory Eye DiseasesInfections of the eye and its appendages:
– blepharitis;
– conjunctivitis;
– keratoconjunctivitis;
– blepharoconjunctivitis;
– keratitis;
– iridocyclitis.
Prevention of postoperative infections.
Active ingredient
Tobramycin
How to take, the dosage
Locally.
Interaction
In case of concomitant administration of tobramycin topically with systemic aminoglycoside antibiotics, there may be increased side effects of systemic nature.
Special Instructions
Contact lenses should not be worn during treatment with the drug.
Long-term use of Tobrex eye drops, as with other antibiotics, may lead to increased growth of non-susceptible microorganisms (including fungi). It is recommended that cultures be taken before and after treatment if the clinical result is unsatisfactory.
Impact on driving and operating machinery
It is not recommended to drive or operate complex machinery, machines, or any other complex equipment that requires visual clarity in patients who have temporarily impaired visual clarity after Tobrex instillation.
Contraindications
Hypersensitivity to the components of the drug.
Side effects
Local. Allergic reaction accompanied by itching and swelling of the eyelids, conjunctival hyperemia, lacrimation.
Overdose
Symptoms: pitting keratitis, erythema, increased lacrimation, itching, and eyelid edema.
Pregnancy use
There is no sufficient experience in using the drug during pregnancy and lactation (breastfeeding). It is possible to use Tobrex eye drops in pregnant women and nursing mothers when the expected therapeutic effect exceeds the potential risk of side effects.
Performance in children
There is no sufficient experience in the use of Tobrex eye drops in children. The drug may be used in children if the expected therapeutic effect exceeds the potential risk of side effects.
Similarities
Tobropt, Tobriss eye drops
Weight | 0.016 kg |
---|---|
Shelf life | 3 years |
Conditions of storage | At a temperature of 8-30 °C |
Manufacturer | Alcon-Couvreur, Belgium |
Medication form | eye drops |
Brand | Alcon-Couvreur |
Related products
Buy Tobrex, eye drops 0.3% 5 ml with delivery to USA, UK, Europe and over 120 other countries.